Poll results: What is your first-line approach to emergent presbyopes who wear contact lenses?

Article

See our latest poll results

Optometry Times® polled our audience with the following question from July 27, 2021 to August 13, 2021:​ What is your first-line approach to emergent presbyopes who wear contact lenses?

The poll appeared on optometrytimes.com and was promoted on various social media channels. Results show a majority of responding ODs' first-line approach to emergent presbyopies who wear contact lenses is multifocal contact lenses.

44 ODs responded, in total. Of these:

• 23 responded "Multifocal contact lenses"

• 10 responded "Monovision contact lenses"

• 10 responded "Low-power readers over single-vision contact lenses"

• 1 responded "Low-power readers over single-vision contact lenses"

Check out our latest poll: Have you or do you plan to implement myopia control into your practice?

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Marc Bloomenstein, OD, FAAO, is a clinical investigator in the trials and overviews the transformative potential of LNZ100.
Devin Sasser, OD, shares his excitement for Acuvue Oasys MAX 1-Day multifocal for astigmatism, the first and only daily disposable multifocal toric contact lens.
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Karen R. Hoffman, OD, speaks on her AOA 2025 poster, which details a case series on fitting patients with irregular cornea and astigmatism with Zenlens (Bausch + Lomb)
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.